Koshinski Asset Management’s AstraZeneca AZN Stock Holding History

Koshinski Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$899K	Buy	4,741 +22	+0.5%	+$4.14K	0.05%	318
2026 Q1	$931K	Buy	4,719 +1,397	+42%	+$269K	0.06%	298
2025 Q4	$611K	Hold	3,322	–	–	0.04%	382
2025 Q3	$510K	Buy	3,322 +36	+1%	+$5.45K	0.03%	413
2025 Q2	$459K	Sell	3,286 -91	-3%	-$12.8K	0.03%	425
2025 Q1	$496K	Sell	3,377 -90	-3%	-$13K	0.04%	378
2024 Q4	$454M	Buy	3,467 +161	+5%	+$22.5K	0.04%	391
2024 Q3	$515K	Sell	3,306 -110	-3%	-$17.8K	0.04%	367
2024 Q2	$524K	Buy	3,416 +1,095	+47%	+$165K	0.05%	330
2024 Q1	$315K	Sell	2,321 -253	-10%	-$33.5K	0.03%	420
2023 Q4	$347K	Sell	2,574 -701	-21%	-$91.1K	0.05%	365
2023 Q3	$444K	Buy	+3,275	New	+$447K	0.05%	353
2022 Q2	–	Sell	-1,071	Closed	-$142K	–	685
2022 Q1	$142K	Buy	1,071 +42	+4%	+$5.04K	0.01%	710
2021 Q4	$120K	Sell	1,029 -24	-2%	-$2.82K	0.01%	788
2021 Q3	$126K	Buy	+1,053	New	+$123K	0.01%	756
2021 Q2	–	Sell	-3,529	Closed	-$206K	–	552
2021 Q1	$206K	Buy	+3,529	New	+$355K	0.02%	563
2020 Q4	–	Sell	-2,304	Closed	-$255	–	544
2020 Q3	$255	Sell	2,304 -1,043	-31%	-$116K	0.03%	431
2020 Q2	$354K	Buy	+3,347	New	+$346K	0.06%	355

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Koshinski Asset Management's AZN Position: Q2 2026 in Review

Koshinski Asset Management increased its AstraZeneca (AZN) stake by 0.47% in Q2 2026, buying an estimated $4.14K and bringing the position to 4,741 shares worth $899K. The position accounts for 0.05% of the portfolio, ranked #318.

Koshinski Asset Management first reported a position in AZN in Q2 2020 and has held it in 18 quarters since. The position peaked at $454M in Q4 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Koshinski Asset Management held 4,741 shares of AstraZeneca worth $899K as of Q2 2026.
Koshinski Asset Management bought 22 AstraZeneca shares in Q2 2026, an estimated $4.14K.
AstraZeneca made up 0.05% of Koshinski Asset Management's portfolio in Q2 2026, its #318 holding.
Koshinski Asset Management first reported a position in AstraZeneca in Q2 2020 and has held it in 18 quarters since.
Koshinski Asset Management's AstraZeneca position peaked at $454M in Q4 2024.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.